telavancin 750 MG Injection

RxCUI
1728082
RxNorm name
telavancin 750 MG Injection
Display name
telavancin 750 MG Injection
Full name
telavancin 750 MG Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:11

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VIBATIVTELAVANCIN HYDROCHLORIDECumberland Pharmaceuticals Inc.5359b759-db7c-4672-9e8a-59c93869bd912025-12-19Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1728082

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9fc67b76-9ba1-45ec-9749-ca3f3a6477d9telavancin 750 MG Injection [PSN] · telavancin 750 MG Injection [SCD] · telavancin (as telavancin hydrochloride) 750 MG Injection [SY]39These highlights do not include all the information needed to use VIBATIV ® (telavancin) safely and effectively. See full prescribing information for VIBATIV. VIBATIV ® (telavancin) for injection, for intravenous use Initial U.S. Approval: 200920140331
5359b759-db7c-4672-9e8a-59c93869bd91telavancin 750 MG Injection [PSN] · telavancin 750 MG Injection [SCD] · telavancin (as telavancin hydrochloride) 750 MG Injection [SY]36These highlights do not include all the information needed to use VIBATIV ® (telavancin) safely and effectively. See full prescribing information for VIBATIV. VIBATIV ® (telavancin) for injection, for intravenous use Initial U.S. Approval: 200920251219